Laden…
Evidence-based risk assessment and known adverse effects
Risk Classification: Unclassified
The risk profile of 5-MAPB has not been fully characterised. Insufficient scientific data is available to draw definitive conclusions.
The following substances carry an elevated risk of adverse interactions with 5-MAPB. This list is not exhaustive.
For a full interaction overview, see the Interactions page.
general
Benzofuran-Empathogene: ähnliches Profil wie MDMA, aber weniger erforscht
health
Kardiovaskuläres Risiko: Herzfrequenz und Blutdruck steigen — bei Herzerkrankungen kontraindiziert
health
Kein Konsum alle 2 Wochen — 5-HT2B-Agonismus könnte bei häufigem Konsum Herzklappenschäden fördern (Hypothese)
combinations
Keine Kombination mit MAO-Hemmern
harm_reduction
Hyperthermie-Risiko bei körperlicher Aktivität — ausreichend Wasser trinken, Temperatur regulieren
dosing
Toleranzentwicklung: mind. 4 Wochen Pause empfohlen (wie MDMA)
Disclaimer: This information is provided for educational purposes only and does not constitute medical advice. If you have concerns about substance use, please consult a qualified healthcare professional or contact a local drug support service.